Analysts' Actions: CRL CVLT LNKD Q WETF

TheStreet.com

NEW YORK (TheStreet) -- CHANGE IN RATINGS

Arcos Dorados Holdings was downgraded to sell at TheStreet Ratings.

Bona Film Group was downgraded to sell at TheStreet Ratings.

Charles River Laboratories was downgraded at Goldman Sachs to sell from neutral. $38 price target. RMS softness adds to preclinical worries, Goldman said.

Commvault was upgraded at Pacific Crest to outperform. $92 price target. Company is gaining market share and should benefit from a new product cycle, Pacific Crest said.

Fusion-io was initiated with a buy rating at Needham. $20 price target. Investor sentiment appears to have bottomed, Needham said.

GATX was downgraded at Stifel Nicolaus to hold from buy. Tank car order rates are not sustainable, Stifel Nicolaus said.

LinkedIn was initiated with an outperform rating at Pacific Crest. $215 price target. Company has clear monetization and scarcity benefits, Pacific Crest said.

Newfield Exploration was upgraded at Stifel Nicolaus to buy from hold. $29 price target. Expect an NAV increase, Stifel Nicolaus said.

People's United Financial was upgraded at J.P. Morgan to overweight from neutral. 15%-plus upside to 2014 consensus and best entry point in two years, J.P. Morgan said.

Quintiles Transnational was initiated at Morgan Stanley with an overweight rating and a $51 price target. The company stands to benefit from being the leader in the high-growth biopharmaceutical R&D outsourcing market.

Quintiles Transnational was initiated at Goldman Sachs with a neutral rating and a $44 price target. The company's global scale and scientific expertise will benefit from the growth in the biopharmaceutical industry, Goldman said.

Quintiles Transnational was initiated with a neutral rating at Robert Baird. $46 price target. Company has low, decelerating growth, Baird said.

Sanderson Farms was downgraded at Keybanc to hold from buy. Valuation call, said Keybanc.

T-Mobile was initiated with a hold rating at Canaccord and a $22 price target. Although TMUS is an attractive takeover candidate, absent such an event the stock appears fully valued, Canaccord said.

WisdomTree Investments was downgraded at Citigroup to neutral. Much of the upside is already priced in to the stock, Citigroup said. Price target was reduced to $13.50.

STOCK COMMENTS/EPS CHANGES

Chipotle price target was boosted at Miller Tabak. Shares are now seen reaching $400. Company should benefit from Qdoba closures, Miller Tabak said. Buy rating.

FedEx estimates were raised at Citigroup for 2014. Volume supports the low end of fourth-quarter guidance and a fuel benefit, said Citi.

Hain Celestial price target and estimates were raised at BMO Capital. Earnings estimates were increased as high single-digit sales growth will be driven by the premium segment and organic opportunities, said BMO Capital. Price target is $69.

Kroger price target and estimates were raised at Cantor Fitzgerald. Reflect accelerated growth from generics and market share gains, said Cantor Fitzgerald. Price target goes to $33.

Pioneer Natural was added to US 1 List at Bank of America/Merrill Lynch. Cash flow can double over the next five years, BofA/Merrill said. $200 price target.

Sodastream price target was raised at Oppenheimer. Shares are now seen reaching $85. Recent channel checks have been encouraging, Oppenheimer said. Outperform rating.

Terex price target, earnings estimates were reduced at BMO Capital. Shares kept their outperform rating despite lowered EPS estimates and a new $36 price target, BMO Capital Markets said. Management blames weakness in European housing sector, BMO also said.

UnitedHealth price target was boosted at Deutsche Bank. Shares are now seen reaching $63. Company is being cautious about 2014 Medicare changes but maintains a strong long-term industry position, Deutsche said. Hold rating.

Williams was cut from Conviction Buy List at Goldman Sachs. $40 price target. Geismar outage likely will hurt earnings, Goldman Sachs said.

>To submit a news tip, email: tips@thestreet.com.

Follow TheStreet on Twitter and become a fan on Facebook.

EXCLUSIVE OFFER: See inside Jim Cramer’s multi-million dollar charitable trust portfolio to see the stocks he thinks could be potentially HUGE winners. Click here to see his holdings for FREE.

View Comments (0)